These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 7529060)

  • 21. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
    Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
    Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.
    Prosper F; Stroncek D; Verfaillie CM
    Blood; 1996 Sep; 88(6):2033-42. PubMed ID: 8822922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ; Shpall EJ; McNiece I; Keller G
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
    Donahue RE; Kirby MR; Metzger ME; Agricola BA; Sellers SE; Cullis HM
    Blood; 1996 Feb; 87(4):1644-53. PubMed ID: 8608259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells.
    Gazitt Y; Reading CC; Hoffman R; Wickrema A; Vesole DH; Jagannath S; Condino J; Lee B; Barlogie B; Tricot G
    Blood; 1995 Jul; 86(1):381-9. PubMed ID: 7540887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
    Menéndez P; Caballero MD; Prosper F; Del Cañizo MC; Pérez-Simón JA; Mateos MV; Nieto MJ; Corral M; Romero M; García-Conde J; Montalbán MA; San Miguel JF; Orfao A
    Transfusion; 2002 Sep; 42(9):1159-72. PubMed ID: 12430673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delineation of T-progenitor cell activity within the CD34+ compartment of adult bone marrow.
    Galy AH; Cen D; Travis M; Chen S; Chen BP
    Blood; 1995 May; 85(10):2770-8. PubMed ID: 7537981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells.
    van der Loo JC; Hanenberg H; Cooper RJ; Luo FY; Lazaridis EN; Williams DA
    Blood; 1998 Oct; 92(7):2556-70. PubMed ID: 9746798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of a candidate human hematopoietic stem-cell population.
    Baum CM; Weissman IL; Tsukamoto AS; Buckle AM; Peault B
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2804-8. PubMed ID: 1372992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primitive hematopoietic progenitor cells are present in peripheral blood autografts.
    Tong J; Gianni AM; Siena S; Srour EF; Bregni M; Hoffman R
    Blood Cells; 1994; 20(2-3):351-62; discussion 362-3. PubMed ID: 7538339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-level expression of a novel epitope of CD59 identifies a subset of CD34+ bone marrow cells highly enriched for pluripotent stem cells.
    Hill B; Rozler E; Travis M; Chen S; Zannetino A; Simmons P; Galy A; Chen B; Hoffman R
    Exp Hematol; 1996 Jul; 24(8):936-43. PubMed ID: 8690053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-metHuG-CSF)-supported cytotoxic chemotherapy.
    Fruehauf S; Haas R; Conradt C; Murea S; Witt B; Möhle R; Hunstein W
    Blood; 1995 May; 85(9):2619-26. PubMed ID: 7537123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice.
    Cashman JD; Lapidot T; Wang JC; Doedens M; Shultz LD; Lansdorp P; Dick JE; Eaves CJ
    Blood; 1997 Jun; 89(12):4307-16. PubMed ID: 9192753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor.
    Gazitt Y; Tian E; Barlogie B; Reading CL; Vesole DH; Jagannath S; Schnell J; Hoffman R; Tricot G
    Blood; 1996 Jan; 87(2):805-11. PubMed ID: 8555506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
    Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
    Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.
    Litzow MR; Brashem-Stein C; Andrews RG; Bernstein ID
    Blood; 1991 Jun; 77(11):2354-9. PubMed ID: 1710150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
    Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of engraftment of CD34(-) and CD34(+) cells from mobilized blood differs from that of CD34(-) and CD34(+) cells from bone marrow.
    Verfaillie CM; Almeida-Porada G; Wissink S; Zanjani ED
    Exp Hematol; 2000 Sep; 28(9):1071-9. PubMed ID: 11008020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.